BK virus infection in transplant recipients: an overview and update.
about
Systematic screening of BK virus by real-time PCR prevents BK virus associated nephropathy in renal transplant recipients.Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation.Repression of BK virus infection of human renal proximal tubular epithelial cells by pravastatin.BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression.Inhibitory interactions between BK and JC virus among kidney transplant recipients.Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.Phylogenetic reconstruction and polymorphism analysis of BK virus VP2 gene isolated from renal transplant recipients in China.An SV40 VP1-derived epitope recognized by CD8+ T cells is naturally processed and presented by HLA-A*0201 and cross-reactive with human polyomavirus determinants.Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection.Clinical significance of quantitative and qualitative detection of BK and JC virus in blood and urine of renal transplantation recipients.Quinolone prophylaxis for the prevention of BK virus infection in kidney transplantation: study protocol for a randomized controlled trial.Viral infection after renal transplantation: surveillance and management.Possible antiviral effect of ciprofloxacin treatment on polyomavirus BK replication and analysis of non-coding control region sequences.High frequency and diversity of rearrangements in polyomavirus bk noncoding regulatory regions cloned from urine and plasma of Israeli renal transplant patients and evidence for a new genetic subtype.Polyomavirus-associated nephropathyImmunity to polyomavirus infection: the polyomavirus-mouse model.Immunophenotyping in BK virus allograft nephropathy distinct from acute rejectionAntirejection treatment in kidney transplant patients with BK viruria.Human polyoma viruses and disease with emphasis on clinical BK and JC.Clinical role of the renal transplant biopsy.Emerging viral diseases in kidney transplant recipients.BK virus nephropathy in a pediatric heart transplant recipient with post-transplant lymphoproliferative disorder: a case report and review of literature.IL28B rs12979860 genotype as a predictor marker of progression to BKVirus Associated nephropathy, after kidney transplantation.Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair.BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft function.BK virus nephropathy complicated with meningoencephalitis after kidney transplantation.Variability in assessing for BK viremia: whole blood is not reliable and plasma is not above reproach - a retrospective analysis.Ureteral stent placement and immediate graft function are associated with increased risk of BK viremia in the first year after kidney transplantation.Incidence of BK polyomavirus infection after kidney transplantation is independent of type of immunosuppressive therapy.Interaction Between Human Polyomavirus BK and Hypoxia Inducible Factor-1 alpha.A Case of BK Nephropathy without Detectable Viremia or Viruria.JC polyomavirus nephropathy confirmed by using an in-house polymerase chain reaction method.Prevalence of BK viremia in Iranian hemodialysis and peritoneal dialysis patients.BK Virus-Associated Nephropathy in Kidney Transplant Recipients.Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy.Treatment of BK viremia after renal transplantation: are fluoroquinolones a false dawn?BK virus large T and VP-1 expression in infected human renal allografts.Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy.Symptomatic BK virus reactivation following fludarabine, cyclophosphamide and rituximab chemotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma.
P2860
Q30224990-8A877AE1-74F8-48EE-BEDC-360F1E21822EQ33376066-0E483D6C-6516-4485-BF87-EA1D8560F827Q34778299-62D755E9-0ABB-4883-B962-55605BC374D3Q35099077-F68FC940-1AAC-41AC-85DA-B46ECA2967FDQ35720604-91596DD1-E95E-45A6-8345-FFE4FB015D54Q36272108-46F4D993-81EA-470C-9536-116BCEC7235AQ36334065-C8EC7E5D-3E0C-4CEE-8821-62522EC23546Q36766174-C443A3DC-B933-4A74-8DD7-D0857C1BBB76Q36846488-99E70599-5A5D-4D4A-9FE6-BC12BA5683E9Q36876460-6AE51A38-6BCA-4E41-BC71-D7CD9A5AE323Q36952467-70166F92-F7FC-4579-9A70-4CFBCD720F3DQ37097708-FC2DF192-0AF0-492A-92F2-220AAED8E833Q37155134-300A7F25-DBFF-495E-9599-6EECCEE997ADQ37191661-7DF3FAE9-17FB-493B-9A13-CEC1E615BE25Q37195470-C0582DA8-0BD4-43BE-AC19-3FD60D46B141Q37223886-BE2723E1-4749-47CC-9134-C2D3D121E07FQ37249853-47894134-50C9-4DB1-A1B7-4F6C6BEE26B6Q37313492-8F18CDC5-DE40-43AC-BA19-44208683E024Q37671117-4BD107EE-5F51-4384-B93B-9769A94A1CD0Q37974480-3113FD1F-1C08-442D-B76A-D9EBF9599F52Q38058285-8888E913-3D58-4E70-8F31-5EF966631470Q38066522-26C16DAF-6117-48FD-AED0-4A01ED6AD56BQ38656414-6ECA47D6-C117-4A96-832E-81C763A1C872Q38658621-61F097FD-7415-472E-AD62-BE1FDAAAE39AQ39309624-D9B6AB01-2905-4AF2-A602-BFDC3C2673CEQ39403250-129C285C-095C-40E1-A863-C9A44C5D883DQ40224753-E276D1D5-56E9-46A7-8595-6D577208303FQ40291483-F3896D55-77D3-4746-A9FA-071EE9941983Q40445539-F898692B-590D-4E81-9DF3-B78A2DF9B0F5Q40537031-993BB116-DA65-48E7-AFAB-C889C6F2E55AQ40925093-19DD44A3-6899-4660-A586-9ACF1CFE36EFQ41054157-12337303-523D-48B9-A436-1BE1B6768C07Q41087673-65C2A191-095F-4863-96F7-414EB2B30F75Q41445948-31037477-66A4-4E81-BE69-3E6EB6FDD63AQ42124720-FB2C4CAB-623D-47D9-BE4D-4E8224DA8E02Q42268339-5B8613BD-84E9-4FA7-A548-FA4143B69ED0Q42420884-33158E19-3314-43FF-940F-78DCF15AEDDAQ43184361-73E631ED-3162-4BBE-83D6-26981A48BA62Q44763558-BC2C2118-2C35-4024-B431-8139C7FDDE37Q45349863-235A2719-B705-494D-8B45-5D2C47A9F1B7
P2860
BK virus infection in transplant recipients: an overview and update.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
BK virus infection in transplant recipients: an overview and update.
@ast
BK virus infection in transplant recipients: an overview and update.
@en
type
label
BK virus infection in transplant recipients: an overview and update.
@ast
BK virus infection in transplant recipients: an overview and update.
@en
prefLabel
BK virus infection in transplant recipients: an overview and update.
@ast
BK virus infection in transplant recipients: an overview and update.
@en
P2860
P1476
BK virus infection in transplant recipients: an overview and update.
@en
P2093
Brennan DC
Randhawa P
P2860
P304
P356
10.1111/J.1600-6143.2006.01403.X
P407
P577
2006-06-09T00:00:00Z